CANY
SGEN

Caxton Associates (New York)’s Seagen Inc. Common Stock SGEN Stock Holding History

Caxton Associates (New York)’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,317
Closed -$649K – 353
2020
Q3 		$649K Sell
3,317
-1,014
-23% -$170K 0.07% 87
2020
Q2 		$736K Buy
+4,331
New +$646K 0.06% 86
2017
Q3 		– Sell
-5,200
Closed -$269K – 651
2017
Q2 		$269K Buy
+5,200
New +$331K 0.01% 454

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caxton Associates (New York)'s SGEN Position: Q4 2020 in Review

Caxton Associates (New York) sold out of Seagen Inc. Common Stock (SGEN) in Q4 2020, closing a stake of 3,317 shares — an estimated $649K sold.

Caxton Associates (New York) first reported a position in SGEN in Q2 2017 and held it in 3 quarters. The position peaked at $736K in Q2 2020. 511 funds tracked by Wall St. Rank hold SGEN as of Q4 2020.

  • Caxton Associates (New York) reported no remaining Seagen Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,317 Seagen Inc. Common Stock shares in Q4 2020, an estimated $649K.
  • Caxton Associates (New York) first reported a position in Seagen Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Caxton Associates (New York)'s Seagen Inc. Common Stock position peaked at $736K in Q2 2020.
  • 511 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2020.

Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.